UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...

Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...

UiPath PATH shares are trading higher on Wednesday. The company recently achieved AIUC 1 certification, setting a new standard for AI agent security and reliability. • How is PATH stock doing now?

Navigating the corridors of (digitally automated) business. Automation accelerates. As a core fundamental truth that has pervaded through the three (some say four) industrial revolutions, every time ...

Robotic process automation (RPA) is a technology that allows enterprises to automate some or all of their business processes. You can think of it as digital workers, which mimic manual tasks, so they ...

A detailed overview of the challenges of benefit claims processing in the public sector, and the benefits of applying agentic automation. It highlights issues like complex eligibility criteria and ...

HITRUST Risk-based, 2-year (r2) Certification validates UiPath is committed to strong cybersecurity and meeting key regulations to protect sensitive data NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH ...

NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation software company, today announced significant upgrades to allow customers to modernize their software testing practices ...

UiPath Inc (NYSE:PATH) penned a deal to expand its partnership with Apprio to offer AI-powered automation solutions for midmarket healthcare companies. Apprio offers technology and service solutions ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.